PNC
RMD icon

Park National Corp’s ResMed RMD Stock Holding History

Park National Corp’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,035
Closed -$215K – 281
2022
Q4 		$215K Buy
1,035
+1
+0.1% +$220 0.01% 255
2022
Q3 		$226K Sell
1,034
-376
-27% -$85.6K 0.01% 245
2022
Q2 		$296K Sell
1,410
-4
-0.3% -$852 0.01% 224
2022
Q1 		$343K Sell
1,414
-68
-5% -$16.4K 0.01% 222
2021
Q4 		$386K Sell
1,482
-7
-0.5% -$1.82K 0.02% 224
2021
Q3 		$392K Buy
1,489
+1
+0.1% +$273 0.02% 225
2021
Q2 		$367K Buy
1,488
+127
+9% +$26.7K 0.02% 232
2021
Q1 		$264K Sell
1,361
-49
-3% -$9.83K 0.01% 264
2020
Q4 		$300K Sell
1,410
-20
-1% -$3.99K 0.01% 245
2020
Q3 		$245K Sell
1,430
-52
-4% -$9.6K 0.01% 251
2020
Q2 		$285K Sell
1,482
-47
-3% -$7.69K 0.02% 243
2020
Q1 		$225K Sell
1,529
-33
-2% -$5.26K 0.01% 262
2019
Q4 		$242K Buy
1,562
+2
+0.1% +$288 0.01% 284
2019
Q3 		$211K Buy
+1,560
New +$204K 0.01% 301

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Park National Corp's RMD Position: Q1 2023 in Review

Park National Corp sold out of ResMed (RMD) in Q1 2023, closing a stake of 1,035 shares — an estimated $215K sold.

Park National Corp first reported a position in RMD in Q3 2019 and held it in 14 quarters. The position peaked at $392K in Q3 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

  • Park National Corp reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
  • Park National Corp sold 1,035 ResMed shares in Q1 2023, an estimated $215K.
  • Park National Corp first reported a position in ResMed in Q3 2019 and held it in 14 quarters.
  • Park National Corp's ResMed position peaked at $392K in Q3 2021.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Park National Corp's 13F filing for Q1 2023, filed 3 Apr 2023.